MORGAN STANLEY
- SEC CIK
- 0000895421
ABBV holding history
AbbVie Inc.
Every 13F filing in which MORGAN STANLEY reported holding ABBV, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 38,901,001 | $9.79B | 0.52% | +884,227+2.3% | Added |
| Q1 2026 | 38,016,774 | $8.27B | 0.50% | −2,025,166−5.1% | Reduced |
| Q4 2025 | 40,041,940 | $9.15B | 0.55% | −1,612,844−3.9% | Reduced |
| Q3 2025 | 41,654,784 | $9.64B | 0.58% | −45,217−0.1% | Reduced |
| Q2 2025 | 41,700,001 | $7.74B | 0.50% | +550,267+1.3% | Added |
| Q1 2025 | 41,149,734 | $8.62B | 0.62% | +1,460,570+3.7% | Added |
| Q4 2024 | 39,689,164 | $7.05B | 0.49% | +972,313+2.5% | Added |
| Q3 2024 | 38,716,851 | $7.65B | 0.55% | +1,473,173+4.0% | Added |
| Q2 2024 | 37,243,678 | $6.39B | 0.49% | −68,271,389−64.7% | Reduced |
| Q1 2024 | 105,515,067 | $19.21B | 0.51% | +37,409,997+54.9% | Added |
| Q4 2023 | 68,105,070 | $10.55B | 0.47% | +35,929,543+111.7% | Added |
| Q3 2023 | 32,175,527 | $4.8B | 0.49% | +914,485+2.9% | Added |
| Q2 2023 | 31,261,042 | $4.21B | 0.42% | −166,952−0.5% | Reduced |
| Q1 2023 | 31,427,994 | $5.01B | 0.54% | −143,756−0.5% | Reduced |
| Q4 2022 | 31,571,750 | $5.1B | 0.58% | +4,785,277+17.9% | Added |
| Q3 2022 | 26,786,473 | $3.6B | 0.49% | +710,939+2.7% | Added |
| Q2 2022 | 26,075,534 | $3.99B | 0.52% | +7,193,804+38.1% | Added |
| Q1 2022 | 18,881,730 | $3.06B | 0.41% | −489,258−2.5% | Reduced |
| Q4 2021 | 19,370,988 | $2.62B | 0.32% | +384,646+2.0% | Added |
| Q3 2021 | 18,986,342 | $2.05B | 0.28% | +41,655+0.2% | Added |
| Q2 2021 | 18,944,687 | $2.13B | 0.28% | +214,425+1.1% | Added |
| Q1 2021 | 18,730,262 | $2.03B | 0.30% | +18,730,262 | New |